One-year clinical outcomes of bivalirudin versus unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention
Diabetes & Metabolic Syndrome: Clinical Research & Reviews, Volume 17, Issue 10, 2023 Oct, Article 102858 | Li, Yulong; Li, Jiawen; Guan, Changdong;…AbstractBackgroundPatients with diabetes and coronary artery disease have a higher risk of bleeding and thrombotic events. However, data on the safety and efficacy of bivalirudin in these patients undergoing elective percutaneous coronary interven… Source